Episode

Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning

Podcast: Hematologic Oncology Update
Published: Dec 4, 2025
Duration seconds: 3123
Processing state: not_requested
Canonical source: https://hematologic-oncology.captivate.fm/episode/5772-oncologytodaycartsafety25
Audio: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/be263928-35f6-4dba-8210-69fc45f096f5.mp3
JSON: /v1/public/podcasts/hematologic-oncology-update-916423/episodes/toxicities-associated-with-car-t-cell-therapy-an-interview-with-dr-matthew-lunning
Markdown: /podcast/hematologic-oncology-update-916423/toxicities-associated-with-car-t-cell-therapy-an-interview-with-dr-matthew-lunning.md

Actions

POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/toxicities-associated-with-car-t-cell-therapy-an-interview-with-dr-matthew-lunning/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/hematologic-oncology-update-916423/toxicities-associated-with-car-t-cell-therapy-an-interview-with-dr-matthew-lunning.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Matthew Lunning from the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska, discusses recent updates on the management of toxicities associated with CAR T-cell therapy.    CME information and select publications here .